申请人:NAKAI Hisao
公开号:US20100063104A1
公开(公告)日:2010-03-11
It is intended to provide a compound represented by the formula (I):
wherein all the symbols are as defined in the description;
which has a p38 MAP kinase inhibitory activity, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. The compound of the invention is useful for preventing or treating a disease in which the abnormal production of a cytokine such as an inflammatory cytokine or a chemokine or overreaction to them is considered to be involved in the cause and aggravation of pathological conditions, in other words, an inflammatory disease, a respiratory disease, a cardiovascular disease, a central nervous system disease or the like, which is a cytokine-mediated disease.
本发明旨在提供一种由公式(I)表示的化合物:其中所有符号如描述中所定义的;其具有p38 MAP激酶抑制活性,其盐,其N-氧化物,其溶剂合物或其前药。本发明的化合物可用于预防或治疗疾病,其中被认为异常产生细胞因子如炎症性细胞因子或趋化因子或对它们过度反应与病理情况的发生和加重有关,换句话说,是细胞因子介导的疾病,例如炎症性疾病,呼吸系统疾病,心血管疾病,中枢神经系统疾病或类似疾病。